Product fact sheet
MitoADAPT MIN 4.0: Technical Specifications & Independent Lab Data
Technical MitoADAPT MIN 4.0 facts covering its eight-wavelength architecture, selectable modes and LightLab six-inch hardware measurements.
A compact eight-wavelength, mode-selectable MitoADAPT panel with a current primary manual path and a LightLab report for the tested MIN 4.0 sample.
buyers comparing mode-selectable spectral hardware, targeted panels with third-party output measurements
buyers who want the simplest two-wavelength control model, anyone treating wavelength count as proof of greater efficacy
Key tradeoff: Its control and wavelength architecture is unusually configurable, but configuration breadth should not be confused with demonstrated clinical superiority.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
The MitoADAPT MIN 4.0 is a compact mode-selectable panel built around eight published peak wavelengths: 590, 630, 660, 670, 810, 830, 850 and 940 nm. Mito also provides a current manual path for the ADAPT family.
Controls are a hardware feature, not an efficacy score
The manufacturer describes eleven selectable wavelength combinations. That makes the control architecture more configurable than a basic two-channel panel, but mode count or wavelength count does not by itself establish better outcomes.
Independent hardware measurements
For the tested MIN 4.0 sample, LightLab reports 112.3 W wall draw, 34.3 W total radiant power, 40.7 mW/cm² average irradiance at six inches, and 56.4 mW/cm² peak irradiance at six inches under its stated test geometry.
The manufacturer’s current family table lists 130 W power consumption. The manufacturer figure and laboratory wall-draw figure are retained separately because one is published nominal data and the other is a measurement from a specific submitted sample.
What the record does not establish
Homeapotherapy has not independently measured each selectable mode or verified that every mode produces equivalent spatial distribution. The LightLab hardware report also does not establish clinical superiority for an eight-wavelength design.
See Red Light Device Specifications Explained before comparing these output figures with manufacturer-meter readings from another brand.
Technical specifications
Published specs and what they mean
Physical
- Panel dimensions
- 9 × 12 in (W × H; panel only) Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
- Weight
- 9 lb Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
Optical
- Published wavelengths
- 590 / 630 / 660 / 670 / 810 / 830 / 850 / 940 nm Basis: Manufacturer published Current manufacturer specification. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
- LED architecture
- 72 lenses / 144 chips Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
- Measured total radiant power
- 34.3 W Basis: Independent lab Conditions: LightLab International ISO/IEC 17025-accredited measurement; report LLIA002765-001. LightLab report LLIA002765-001. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
- Average irradiance at 6 in
- 40.7 mW/cm² Basis: Independent lab Conditions: Six inches; Area Below LEDs spatial averaging; 380–1000 nm; report LLIA002765-001. LightLab spatial average for the tested sample. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
- Peak irradiance at 6 in
- 56.4 mW/cm² Basis: Independent lab Conditions: Six inches; 380–1000 nm; report LLIA002765-001. LightLab peak for the tested sample. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
Electrical
- Published power consumption
- 130 W Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
- Measured wall draw
- 112.3 W Basis: Independent lab Conditions: LightLab International; six-inch device distance; Area Below LEDs geometry; report LLIA002765-001. LightLab report LLIA002765-001; tested 2025-09-12. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
Controls
- Running modes
- 11 selectable wavelength combinations Basis: Manufacturer published Manufacturer describes eleven mode-selectable wavelength combinations. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
What the current record does not establish
- Homeapotherapy has not independently verified each selectable mode's output.
- The normalized LightLab values describe the reported test configuration and sample.
- No clinical ranking is inferred from eight-wavelength capability.
A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Dose and irradiance context
What the output number means over time
Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.
Neutral conversion from the independent average measurement
Normalized measured average: 40.7 mW/cm².
Measurement conditions: Six inches; Area Below LEDs spatial averaging; 380–1000 nm; report LLIA002765-001.
- 1 minute
- 2.44 J/cm²
- 5 minutes
- 12.21 J/cm²
- 10 minutes
- 24.42 J/cm²
- 20 minutes
- 48.84 J/cm²
These figures are arithmetic translations of one independently measured area-average irradiance. They are not suggested session lengths, target fluences or evidence that the same irradiance reaches tissue at a different distance, body contour, device mode or treatment geometry.
What this calculation still cannot tell you
- whether this is an effective dose for any condition;
- how irradiance changes at a different distance or across curved anatomy;
- how much energy reaches tissue below the surface;
- whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
- whether peak irradiance would produce the same area exposure as the average value shown here.
Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.
Clinical evidence context
Where these wavelengths overlap with human research
Published device wavelengths: 590 / 630 / 660 / 670 / 810 / 830 / 850 / 940 nm.
This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.
Research areas worth checking
- Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
- Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
- Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
- Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
- Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
- Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
- See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.
Do not infer from wavelength overlap
- that this device is clinically proven for the linked condition;
- that more wavelengths are better;
- that the highest published irradiance is the best dose;
- that an open wound should be treated with a consumer device without appropriate wound assessment.
For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.
Safety first
What should make you slow down?
Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
No merchant destination is currently tracked for this product.
Source trail
Primary documents and supporting evidence
- MitoADAPT 4.0 Red Light Therapy Panel SeriesMito Red Light · Manufacturer · retrieved 2026-08-11
- Independent ISO/IEC 17025 Panel Test DataMito Red Light / LightLab International · Independent lab · HTML data index · retrieved 2026-08-11
- Product Manuals & VideosMito Red Light · Manufacturer manual · Manual index · retrieved 2026-08-11